Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Arcadia Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 29 | 15 | −14 |
| Shares | 2.37M | 161.9K | −2.20M (−93.2%) |
| Value | $639.5K | $1.21M | +$569.6K (+89.1%) |
New holders (4)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 52,874 | $395.0K | 1.47% |
| UBS Group AG | 3,209 | $24.0K | 0.00% |
| FMR LLC | 8 | $60 | 0.00% |
| US Bancorp | 5 | $37 | 0.00% |
Sold out (18)
Institutions that held Arcadia Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Vanguard Group Inc | 307,300 | $83.3K |
| Susquehanna International Group, LLP | 282,419 | $76.5K |
| Citadel Advisors LLC | 181,437 | $49.2K |
| Geode Capital Management, LLC | 177,475 | $48.0K |
| Renaissance Technologies LLC | 144,500 | $39.0K |
| HRT Financial LP | 83,183 | $22.0K |
| HighTower Advisors, LLC | 63,883 | $16.0K |
| Jane Street Group, LLC | 54,573 | $14.8K |
| Ergoteles LLC | 46,534 | $12.6K |
| LPL Financial LLC | 41,000 | $11.1K |
| Northern Trust Corp | 28,929 | $7.84K |
| Virtu Financial LLC | 13,123 | $4.00K |
| Two Sigma Securities, LLC | 14,149 | $3.83K |
| Calton & Associates, Inc. | 13,000 | $3.52K |
| Goldman Sachs Group Inc | 11,033 | $2.99K |
| The PNC Financial Services Group, Inc. | 200 | $54 |
| Simplex Trading, LLC | 255 | $0 |
| VitalStone Financial, LLC | 4 | $0 |